# Kaléo signs first DoD contract for ROCS auto-injectors

Kaléo has executed a contract with the U.S. Department of Defense for the manufacture and delivery of up to 788,000 ROCS auto-injectors, a naloxone antidote for weaponized opioids.

- Type: Contract
- Announced: 2022-09-21
- Where: United States
- Status: completed
- Products: ROCS auto-injectors, naloxone hydrochloride injection
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [U.S. Department of Defense](https://endata.com/companies/4836.md) (customer)
- [Kaléo](https://endata.com/companies/65444.md) (supplier)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2022/09/21/2520123/0/en/Kal%C3%A9o-Announces-First-U-S-Department-of-Defense-Supply-Contract-for-the-Rapid-Opioid-Countermeasure-System-ROCS-Antidote-for-Ultra-Potent-Weaponized-Opioids.html), 2022-09-21: "Kaléo today announced the execution of the first contract with the U.S. Department of Defense (DoD) for the procurement of the Rapid Opioid Countermeasure System (ROCS)."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.